why choose us

First received: July 21, 2022

Clinical Trial: Phase 2 Study of DKN-01 in Colorectal Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)

Brief Summary: This is a Phase 2 randomized, open-label, two-part, multicenter study with a safety run-in to evaluate efficacy and safety of DKN-01 plus FOLFIRI/FOLFOX and bevacizumab versus standard of care (SOC) [FOLFIRI/FOLFOX and bevacizumab] as second-line treatment of advanced CRC patients.

Read more